CN103060080B - 一种降血脂茶油的制备方法 - Google Patents
一种降血脂茶油的制备方法 Download PDFInfo
- Publication number
- CN103060080B CN103060080B CN2013100035928A CN201310003592A CN103060080B CN 103060080 B CN103060080 B CN 103060080B CN 2013100035928 A CN2013100035928 A CN 2013100035928A CN 201310003592 A CN201310003592 A CN 201310003592A CN 103060080 B CN103060080 B CN 103060080B
- Authority
- CN
- China
- Prior art keywords
- tea oil
- standby
- preparation
- fat
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000010495 camellia oil Substances 0.000 title claims abstract description 133
- 238000002360 preparation method Methods 0.000 title claims abstract description 49
- 240000002234 Allium sativum Species 0.000 claims abstract description 27
- 240000007087 Apium graveolens Species 0.000 claims abstract description 27
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims abstract description 27
- 235000010591 Appio Nutrition 0.000 claims abstract description 27
- 235000004611 garlic Nutrition 0.000 claims abstract description 27
- 240000001548 Camellia japonica Species 0.000 claims abstract description 25
- 240000008042 Zea mays Species 0.000 claims abstract description 25
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 25
- 235000018597 common camellia Nutrition 0.000 claims abstract description 25
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 24
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 24
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 24
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 24
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 24
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 24
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 24
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 24
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 24
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 24
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 24
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 24
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 24
- 235000005822 corn Nutrition 0.000 claims abstract description 24
- 241000972773 Aulopiformes Species 0.000 claims abstract description 21
- 235000019515 salmon Nutrition 0.000 claims abstract description 21
- 238000012545 processing Methods 0.000 claims abstract description 15
- 238000001914 filtration Methods 0.000 claims abstract description 13
- 239000011347 resin Substances 0.000 claims abstract description 12
- 229920005989 resin Polymers 0.000 claims abstract description 12
- 239000003513 alkali Substances 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims abstract description 6
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims abstract description 5
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims abstract description 5
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims description 30
- 235000002566 Capsicum Nutrition 0.000 claims description 27
- 235000013372 meat Nutrition 0.000 claims description 24
- 241001092040 Crataegus Species 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 22
- 239000001390 capsicum minimum Substances 0.000 claims description 21
- 230000008569 process Effects 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 13
- 241000208293 Capsicum Species 0.000 claims description 11
- 238000004140 cleaning Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000010521 absorption reaction Methods 0.000 claims description 7
- 238000000643 oven drying Methods 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 238000001223 reverse osmosis Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012670 alkaline solution Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000002203 pretreatment Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 239000013049 sediment Substances 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 240000008574 Capsicum frutescens Species 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 239000000463 material Substances 0.000 abstract description 8
- 235000019198 oils Nutrition 0.000 abstract description 5
- 230000000050 nutritive effect Effects 0.000 abstract description 3
- 235000019484 Rapeseed oil Nutrition 0.000 abstract description 2
- 239000008157 edible vegetable oil Substances 0.000 abstract 3
- OFQCQIGMURIECL-UHFFFAOYSA-N 2-[2-(diethylamino)ethyl]-2',6'-dimethylspiro[isoquinoline-4,4'-oxane]-1,3-dione;phosphoric acid Chemical compound OP(O)(O)=O.O=C1N(CCN(CC)CC)C(=O)C2=CC=CC=C2C21CC(C)OC(C)C2 OFQCQIGMURIECL-UHFFFAOYSA-N 0.000 abstract 2
- 235000002568 Capsicum frutescens Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000005406 washing Methods 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 26
- 230000000694 effects Effects 0.000 description 13
- 235000019197 fats Nutrition 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 9
- 238000012360 testing method Methods 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 6
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- -1 sucrose fatty ester Chemical class 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 241000269849 Thunnus Species 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 208000003643 Callosities Diseases 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 3
- 208000035150 Hypercholesterolemia Diseases 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 235000006008 Brassica napus var napus Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000002633 protecting effect Effects 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 1
- 241000526900 Camellia oleifera Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 229940122502 Cholesterol absorption inhibitor Drugs 0.000 description 1
- 229940123239 Cholesterol synthesis inhibitor Drugs 0.000 description 1
- 208000031288 Combined hyperlipidaemia Diseases 0.000 description 1
- 244000086443 Craterellus fallax Species 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000006004 Quartz sand Substances 0.000 description 1
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 206010048214 Xanthoma Diseases 0.000 description 1
- 206010048215 Xanthomatosis Diseases 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005370 atorvastatin Drugs 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000008085 high protein diet Nutrition 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical class OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- FYPMFJGVHOHGLL-UHFFFAOYSA-N probucol Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1SC(C)(C)SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FYPMFJGVHOHGLL-UHFFFAOYSA-N 0.000 description 1
- 229960003912 probucol Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229960000672 rosuvastatin Drugs 0.000 description 1
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 229960002855 simvastatin Drugs 0.000 description 1
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Edible Oils And Fats (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013100035928A CN103060080B (zh) | 2013-01-06 | 2013-01-06 | 一种降血脂茶油的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013100035928A CN103060080B (zh) | 2013-01-06 | 2013-01-06 | 一种降血脂茶油的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103060080A CN103060080A (zh) | 2013-04-24 |
CN103060080B true CN103060080B (zh) | 2013-11-20 |
Family
ID=48102984
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013100035928A Active CN103060080B (zh) | 2013-01-06 | 2013-01-06 | 一种降血脂茶油的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103060080B (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103392853B (zh) * | 2013-07-08 | 2014-12-24 | 广西壮族自治区农业科学院蔬菜研究所 | 一种前列腺保健芥蓝茶及其制备方法 |
CN103409235B (zh) * | 2013-08-12 | 2016-05-11 | 江苏惠康生物有限公司 | 一种米糠一级油的脱色方法 |
CN103891923B (zh) * | 2014-03-11 | 2016-05-11 | 安徽亿宏生物科技有限公司 | 一种保健茶油及其制备方法 |
CN105831733A (zh) * | 2016-03-23 | 2016-08-10 | 管天球 | 一种茶油降脂胶囊 |
CN106234635A (zh) * | 2016-08-12 | 2016-12-21 | 贵州省玉屏县金心笛油脂开发有限公司 | 一种用于调节血脂的山茶油及其制备方法 |
CN106260112A (zh) * | 2016-08-12 | 2017-01-04 | 贵州省玉屏县金心笛油脂开发有限公司 | 一种玫瑰花香山茶油及其制备方法 |
CN106106859A (zh) * | 2016-08-12 | 2016-11-16 | 贵州省玉屏县金心笛油脂开发有限公司 | 一种菊花香山茶油及其制备方法 |
CN106190534A (zh) * | 2016-08-16 | 2016-12-07 | 贵州石阡佛顶山野生油茶油业有限公司 | 一种降血压茶油的制备方法 |
CN106539990A (zh) * | 2016-10-12 | 2017-03-29 | 贵州省黎平县黔香园油脂有限公司 | 一种药用茶油的配方 |
CN107213329A (zh) * | 2017-06-14 | 2017-09-29 | 贵州祥驰农业开发有限公司 | 一种中药保健茶油 |
CN108634013A (zh) * | 2018-04-20 | 2018-10-12 | 管天球 | 一种预防脑血管硬化茶油的制备方法 |
CN108719493A (zh) * | 2018-04-20 | 2018-11-02 | 管天球 | 一种预防高血脂茶油的制备方法 |
CN108634014A (zh) * | 2018-04-20 | 2018-10-12 | 管天球 | 一种预防心血管病茶油的制备方法 |
CN110184117A (zh) * | 2019-06-11 | 2019-08-30 | 太湖县润乐植物油厂 | 一种浓香食用保健菜籽油的加工工艺 |
CN110122597A (zh) * | 2019-06-11 | 2019-08-16 | 太湖县润乐植物油厂 | 一种茶籽油及其制备方法 |
CN113767989A (zh) * | 2021-09-16 | 2021-12-10 | 湖南省金昭阳农业科技股份有限公司 | 一种降压降脂软化血管的食用油及其制备方法 |
CN117448074A (zh) * | 2023-10-08 | 2024-01-26 | 江西神州通油茶科技有限公司 | 一种改良茶油苦味的加工方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101124928A (zh) * | 2007-09-24 | 2008-02-20 | 张国浩 | 一种含ω-3多不饱和脂肪酸的营养均衡调和油及其生产方法 |
CN101942355A (zh) * | 2010-08-20 | 2011-01-12 | 上海师范大学 | 从茶叶籽或油茶籽中提取茶籽油、茶皂素、茶籽多糖的综合提取方法 |
CN102058727A (zh) * | 2009-11-16 | 2011-05-18 | 桂林莱茵生物科技股份有限公司 | 含神经酰胺的茶籽提取物及其制备方法 |
CN102212417A (zh) * | 2011-05-16 | 2011-10-12 | 四川农业大学 | 一种有效的山茶油精制方法 |
CN102669303A (zh) * | 2012-05-05 | 2012-09-19 | 管天球 | 一种富角鲨烯茶油的制备方法 |
CN102669304A (zh) * | 2012-05-05 | 2012-09-19 | 管天球 | 一种富硒茶油及其制备方法 |
-
2013
- 2013-01-06 CN CN2013100035928A patent/CN103060080B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101124928A (zh) * | 2007-09-24 | 2008-02-20 | 张国浩 | 一种含ω-3多不饱和脂肪酸的营养均衡调和油及其生产方法 |
CN102058727A (zh) * | 2009-11-16 | 2011-05-18 | 桂林莱茵生物科技股份有限公司 | 含神经酰胺的茶籽提取物及其制备方法 |
CN101942355A (zh) * | 2010-08-20 | 2011-01-12 | 上海师范大学 | 从茶叶籽或油茶籽中提取茶籽油、茶皂素、茶籽多糖的综合提取方法 |
CN102212417A (zh) * | 2011-05-16 | 2011-10-12 | 四川农业大学 | 一种有效的山茶油精制方法 |
CN102669303A (zh) * | 2012-05-05 | 2012-09-19 | 管天球 | 一种富角鲨烯茶油的制备方法 |
CN102669304A (zh) * | 2012-05-05 | 2012-09-19 | 管天球 | 一种富硒茶油及其制备方法 |
Non-Patent Citations (6)
Title |
---|
吴文鹤等.茶皂素对高脂血症模型大鼠血液流变学、心肌酶活性的影响.《湖北民族学院学报(医学版)》.2009,(第04期), |
大孔树脂法纯化茶皂素研究;张海龙 等;《Book of Abstracts of 14th ICC Cereal and Bread Congress and Forum on Fats and Oils》;20121231;320-321 * |
张海龙 等.大孔树脂法纯化茶皂素研究.《Book of Abstracts of 14th ICC Cereal and Bread Congress and Forum on Fats and Oils》.2012, |
李升锋等.茶皂素性质、提取、精制及应用.《粮食与油脂》.2003,(第11期), |
茶皂素对高脂血症模型大鼠血液流变学、心肌酶活性的影响;吴文鹤等;《湖北民族学院学报(医学版)》;20090430(第04期);14-16 * |
茶皂素性质、提取、精制及应用;李升锋等;《粮食与油脂》;20031110(第11期);17-18 * |
Also Published As
Publication number | Publication date |
---|---|
CN103060080A (zh) | 2013-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103060080B (zh) | 一种降血脂茶油的制备方法 | |
CN104137952B (zh) | 一种犬、猫用心脏健康维护营养粮及其制作方法 | |
CN106962506A (zh) | 一种调和油及其制备方法 | |
CN101919452B (zh) | 一种复合油保健食品 | |
CN102239934A (zh) | 一种复合山茶油制剂 | |
CN103156198A (zh) | 一种鱼油软胶囊及其制备方法 | |
CN106260110A (zh) | 一种具有胃肠保健功能的山茶油液体制剂 | |
CN103082034A (zh) | 一种保健调和油 | |
CN106118870A (zh) | 一种营养保健茶油 | |
CN106106851A (zh) | 一种调和油及其制备工艺 | |
CN101822754B (zh) | 葡萄籽提取物的双频超声辅助提取方法及作为脂肪酶抑制剂的应用 | |
CN106234635A (zh) | 一种用于调节血脂的山茶油及其制备方法 | |
WO2015021631A1 (zh) | 一种黄芪籽粗油、精制油及制备方法与应用 | |
CN108651635A (zh) | 具有健脑补脑功效的营养均衡的健康食用油 | |
CN103478295B (zh) | 一种补钙保健葡萄籽油 | |
CN103478560B (zh) | 一种用牛奶和绞股蓝制造的营养大米 | |
Selvaraj et al. | Virgin coconut oil: A nutraceutical and therapeutic food | |
CN1166386C (zh) | 益智胶囊 | |
CN105124566A (zh) | 大鲵油、杜仲籽油和红曲米、山楂果、红茶提取物的混合物软胶囊制备及保健作用 | |
CN108902357A (zh) | 一种降血脂茶油的制备方法 | |
CN106729086A (zh) | 一种具有降血脂功能的保健胶囊 | |
CN104606164B (zh) | 一种红花精华素胶囊的制备方法 | |
CN106262877A (zh) | 一种富集不饱和脂肪酸的营养粉 | |
CN101558878B (zh) | 含牡丹叶的降血压、降血脂袋泡茶及其制作方法 | |
CN109430847A (zh) | 一种茶油软胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160816 Address after: 426100 Yongzhou City, Hunan province Qiyang county Wu Xi Zhen Qi Li Xin Cun, Hunan Jin Hao tea oil industry Limited by Share Ltd Patentee after: HUNAN XINJINHAO TEA OIL Co.,Ltd. Address before: 426100 Yongzhou City, Hunan province Qiyang county Wu Xi Zhen Qi Li Industrial Village Patentee before: HUNAN JINHAO CAMELLIA OIL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for preparing lipid-lowering tea oil Granted publication date: 20131120 Pledgee: Hunan Xiangjiang New Area Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XINJINHAO TEA OIL Co.,Ltd. Registration number: Y2024980017243 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |